Back to News
Market Impact: 0.65

Owens & Minor Q2 Net Loss Sharply Widens

OMINDAQ
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesHealthcare & Biotech
Owens & Minor Q2 Net Loss Sharply Widens

Owens & Minor (OMI) reported a sharply widened second-quarter net loss of $869.06 million, or $11.30 per share, and a loss from continuing operations of $83.82 million, or $1.09 per share. While adjusted income from continuing operations marginally increased to $0.26 per share, missing analyst estimates of $0.28, the company's reported net revenues of $681.92 million fell dramatically short of the $2.73 billion consensus, signaling a significant top-line miss despite year-over-year growth.

Analysis

Owens & Minor (OMI) reported exceptionally weak second-quarter results, defined by a sharply widening GAAP net loss and a severe top-line miss. The net loss ballooned to $869.06 million, or $11.30 per share, a dramatic deterioration from a loss of $31.91 million in the prior-year period. Similarly, the loss from continuing operations expanded to $83.82 million. While adjusted income from continuing operations showed a marginal increase to $0.26 per share from $0.25 year-over-year, this figure failed to meet the analyst consensus of $0.28 per share. The most significant red flag is the revenue performance; net revenues of $681.92 million, despite growing from $660.40 million, fell dramatically short of the $2.73 billion consensus estimate. This substantial revenue miss, coupled with the earnings shortfall and expanding losses, signals severe operational or structural challenges. The company's decision to withhold its 2025 financial outlook until its earnings call introduces further uncertainty for investors.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo